Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population
Authors
Keywords
-
Journal
CLINICAL BIOCHEMISTRY
Volume 121-122, Issue -, Pages 110680
Publisher
Elsevier BV
Online
2023-10-24
DOI
10.1016/j.clinbiochem.2023.110680
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Robustness of CSF Aβ42/40 and Aβ42/P‐tau181 measured using fully automated immunoassays to detect AD‐related outcomes
- (2023) Antoine Leuzy et al. Alzheimers & Dementia
- Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury
- (2023) Sophie Stukas et al. NEUROLOGY
- Serum GFAP – pediatric reference interval in a cohort of Danish children
- (2023) Lea Tybirk et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The dynamics of plasma biomarkers across the Alzheimer’s continuum
- (2023) Yu Guo et al. Alzheimers Research & Therapy
- Pediatric reference intervals for serum neurofilament light and glial fibrillary acidic protein using the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) cohort
- (2023) Sophie Stukas et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Blood GFAP as an emerging biomarker in brain and spinal cord disorders
- (2022) Ahmed Abdelhak et al. Nature Reviews Neurology
- Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET
- (2022) Cécile Tissot et al. EBioMedicine
- Serum glial fibrillary acidic protein is a body fluid biomarker: A valuable prognostic for neurological disease – A systematic review
- (2022) Luana Heimfarth et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
- (2022) Pascal Benkert et al. LANCET NEUROLOGY
- Brain charts for the human lifespan
- (2022) R. A. I. Bethlehem et al. NATURE
- Performance of plasma phosphorylated tau 181 and 217 in the community
- (2022) Michelle M. Mielke et al. NATURE MEDICINE
- The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
- (2022) Oskar Hansson et al. Alzheimers & Dementia
- Contributors to Serum NfL Levels in People without Neurologic Disease
- (2022) Kathryn C. Fitzgerald et al. ANNALS OF NEUROLOGY
- Plasma neurofilament light chain (NfL) reference interval determination in an Age-stratified cognitively unimpaired cohort
- (2022) Joshua A. Bornhorst et al. CLINICA CHIMICA ACTA
- Serum GFAP – reference interval and preanalytical properties in Danish adults
- (2022) Lea Tybirk et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
- (2022) Abby L. Brand et al. Alzheimers Research & Therapy
- Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
- (2022) Joseph Therriault et al. JAMA Neurology
- Biomarkers for neurodegenerative diseases
- (2021) Oskar Hansson NATURE MEDICINE
- A multicentre validation study of the diagnostic value of plasma neurofilament light
- (2021) Nicholas J. Ashton et al. Nature Communications
- Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities
- (2021) Jeremy A. Syrjanen et al. Alzheimers & Dementia
- Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group
- (2021) Inge M. W. Verberk et al. Alzheimers & Dementia
- Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
- (2021) Johan Gobom et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
- (2021) Charlotte E Teunissen et al. LANCET NEUROLOGY
- Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques
- (2021) Yan Li et al. NEUROLOGY
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Multiple smoothing parameters selection in additive regression quantiles
- (2020) Vito M.R. Muggeo et al. STATISTICAL MODELLING
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
- (2019) Lih-Fen Lue et al. Frontiers in Aging Neuroscience
- Plasma β-amyloid 1–42 reference values in cognitively normal subjects
- (2018) Chiara Zecca et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Estimating growth charts via nonparametric quantile regression: a practical framework with application in ecology
- (2012) Vito M. R. Muggeo et al. ENVIRONMENTAL AND ECOLOGICAL STATISTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started